NEET UG 2026 registration has begun, with the application window open until March 8, 2026. Eligible candidates can submit their applications online at neet.nta.nic.in for admission to MBBS, BDS, AYUSH, and BSc Nursing courses. The NEET UG 2026 exam will be conducted on May 3, 2026.
GPAT 2026 application correction window is now open for registered candidates on the NBEMS portal at natboard.edu.in. The last date to make corrections is 09 February 2026, while the examination will be held on 07 March 2026.
The MAH BHMCT CET 2026 registration is now open. Candidates can submit their online applications on the official website, cetcell.mahacet.org, until February 16, 2026. The entrance examination will be conducted from April 28 to 30, 2026.
| Course Name | Fees | Eligibility |
| B.Pharm. (Bachelor of Pharmacy) | 10+2 education from a recognized board, minimum aggregate of 45% in Physics, Chemistry, and Biology/Mathematics, appeared for Common Entrance Test (CET) or equivalent entrance exam | |
| M.Pharm. (Master of Pharmacy) | ₹2,20,000 | Bachelor of Pharmacy (B.Pharm.) degree, minimum aggregate of 55%, valid GPAT score |
| Diploma in Pharmacy | 10+2 examination, Minimum aggregate of 45% in the science stream, Passed in Physics, Passed in Chemistry, Passed in Biology, Passed in Mathematics |
| Gender | Male | Female |
|---|---|---|
| Total | 29 | 22 |
| OBC | 2 | 5 |
| SC | 0 | 3 |
| ST | 0 | 0 |
| Muslim | 0 | 1 |
| PWD | 0 | 0 |
| Minority Community | 27 | 13 |
| Gender | Male | Female |
|---|---|---|
| General | 32 | 42 |
| OBC | 6 | 7 |
| SC | 1 | 1 |
| ST | 0 | 0 |
| Muslim | 9 | 5 |
| PWD | 0 | 0 |
Dear student, St. John Institute of Pharmacy and Research in Palghar has a placement rate of 40% for postgraduate programs and 50% for undergraduate programs. The median salary for PG students is Rs 2.80 LPA, while UG students receive a median package of Rs 2.25 LPA.
Dear student, no, for B Pharmacy NEET scores are not accepted. NEET (National Eligibility cum Entrance Test) is primarily for medical courses like MBBS and BDS.